Researchers develop a caspase inhibitor that only works after being irradiated with UV light, giving them control over apoptosis in human cells.

A new inhibitor gives researchers the ability to control programmed cell death in cultured human T cells.

At Bessy II, a synchrotron radiation facility in Berlin, scientists use X-rays to study the structure of SARS-CoV-2.

An enzyme blocker is highly effective at treating intestinal parasitic infection in mice.

In an in vitro study, the compound completely blocked the replication of rhinoviruses.

Meet some of the people featured in the April 2012 issue of The Scientist.